196 related articles for article (PubMed ID: 19566585)
1. Clinical outcome and IL-17, IL-23, IL-27 and FOXP3 expression in peripheral blood mononuclear cells of pollen-allergic children during sublingual immunotherapy.
Nieminen K; Valovirta E; Savolainen J
Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e174-84. PubMed ID: 19566585
[TBL] [Abstract][Full Text] [Related]
2. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
Savolainen J; Jacobsen L; Valovirta E
Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
[TBL] [Abstract][Full Text] [Related]
3. Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy.
Savolainen J; Nieminen K; Laaksonen K; Laiho T; Jacobsen L; Lahesmaa R; Terho EO; Valovirta E
Allergy; 2007 Aug; 62(8):949-53. PubMed ID: 17620074
[TBL] [Abstract][Full Text] [Related]
4. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells.
Scadding GW; Shamji MH; Jacobson MR; Lee DI; Wilson D; Lima MT; Pitkin L; Pilette C; Nouri-Aria K; Durham SR
Clin Exp Allergy; 2010 Apr; 40(4):598-606. PubMed ID: 20184605
[TBL] [Abstract][Full Text] [Related]
5. Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy.
Bonvalet M; Moussu H; Wambre E; Ricarte C; Horiot S; Rimaniol AC; Kwok WW; Horak F; de Beaumont O; Baron-Bodo V; Moingeon P
Clin Exp Allergy; 2012 Dec; 42(12):1745-55. PubMed ID: 23181790
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
Valovirta E; Jacobsen L; Ljørring C; Koivikko A; Savolainen J
Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of allergen-induced in vitro interleukin-10 and interleukin-18 mRNA in peripheral blood mononuclear cells of allergic rhinitis patients after specific immunotherapy.
Savolainen J; Laaksonen K; Rantio-Lehtimäki A; Terho EO
Clin Exp Allergy; 2004 Mar; 34(3):413-9. PubMed ID: 15005735
[TBL] [Abstract][Full Text] [Related]
8. Three-year follow-up study of allergen-induced in vitro cytokine and signalling lymphocytic activation molecule mRNA responses in peripheral blood mononuclear cells of allergic rhinitis patients undergoing specific immunotherapy.
Nieminen K; Laaksonen K; Savolainen J
Int Arch Allergy Immunol; 2009; 150(4):370-6. PubMed ID: 19571569
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis.
Mäkelä MJ; Gyllfors P; Valovirta E; Steffensen MA; Grønager PM; Savolainen J; Winther L
Clin Ther; 2018 Apr; 40(4):574-586.e4. PubMed ID: 29551533
[TBL] [Abstract][Full Text] [Related]
10. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
[TBL] [Abstract][Full Text] [Related]
11. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.
Burastero SE; Mistrello G; Falagiani P; Paolucci C; Breda D; Roncarolo D; Zanotta S; Monasterolo G; Rossi RE
Ann Allergy Asthma Immunol; 2008 Apr; 100(4):343-50. PubMed ID: 18450120
[TBL] [Abstract][Full Text] [Related]
12. IL-22 mRNA in peripheral blood mononuclear cells from allergic rhinitic and asthmatic pediatric patients.
Farfariello V; Amantini C; Nabissi M; Morelli MB; Aperio C; Caprodossi S; Carlucci A; Bianchi AM; Santoni G
Pediatr Allergy Immunol; 2011 Jun; 22(4):419-23. PubMed ID: 21535180
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
14. Enhanced sublingual immunotherapy by TAT-fused recombinant allergen in a murine rhinitis model.
Salari F; Vahedi F; Varasteh AR; Ketabdar H; Chamani J; Sankian M
Int Immunopharmacol; 2017 Jul; 48():118-125. PubMed ID: 28501765
[TBL] [Abstract][Full Text] [Related]
15. Innate and lymphocytic response of birch-allergic patients before and after sublingual immunotherapy.
Guida G; Boita M; Scirelli T; Bommarito L; Heffler E; Badiu I; Bellone G; Mietta S; Mistrello G; Rolla G
Allergy Asthma Proc; 2012; 33(5):411-5. PubMed ID: 22762741
[TBL] [Abstract][Full Text] [Related]
16. Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.
Rolinck-Werninghaus C; Kopp M; Liebke C; Lange J; Wahn U; Niggemann B
Int Arch Allergy Immunol; 2005 Feb; 136(2):134-41. PubMed ID: 15650310
[TBL] [Abstract][Full Text] [Related]
17. Role of IL-35 in sublingual allergen immunotherapy.
Shamji MH; Layhadi JA; Achkova D; Kouser L; Perera-Webb A; Couto-Francisco NC; Parkin RV; Matsuoka T; Scadding G; Ashton-Rickardt PG; Durham SR
J Allergy Clin Immunol; 2019 Mar; 143(3):1131-1142.e4. PubMed ID: 30053528
[TBL] [Abstract][Full Text] [Related]
18. Effect of Lactobacillus rhamnosus GG and vitamin D supplementation on the immunologic effectiveness of grass-specific sublingual immunotherapy in children with allergy.
Jerzynska J; Stelmach W; Balcerak J; Woicka-Kolejwa K; Rychlik B; Blauz A; Wachulec M; Stelmach P; Majak P; Stelmach I
Allergy Asthma Proc; 2016 Jul; 37(4):324-34. PubMed ID: 27401319
[TBL] [Abstract][Full Text] [Related]
19. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.
Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H
Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
